MedPath

the role of magnesium sulphate along with local analgesia for pain reduction for episiotomy for child birth

Phase 3
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Registration Number
CTRI/2023/01/049097
Lead Sponsor
AIIMS Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All Pregnant females delivered by vaginal route requiring episiotomy (mediolateral type)

Exclusion Criteria

1-Antenatal females not willing to participate in the study.

2- Allergy to local anaesthetics agents or MgSO4.

3- Those who received epidural analgesia in labour.

4- 3rd degree perineal tear/ complete perineal tear (CPT).

5- Instrumental delivery.

6- Third stage complications like uterine inversion, PPH.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
VAS ScoreTimepoint: 0, 2, and 6 hours
Secondary Outcome Measures
NameTimeMethod
To compare the requirement of extra analgesia in both the groups up to 6 hours after episiotomyTimepoint: 6 hours after episiotomy;To study the satisfaction level of patient with MgSo4 â?? lignocaine Vs lignocaine injection during perineal repair following vaginal birth using LINKERT scaleTimepoint: 2 hours;To study the side effects and any voiding difficulties till 6 hours of episiotomy repairTimepoint: 6 hours
© Copyright 2025. All Rights Reserved by MedPath